WO2014123381A1 - Medical device provided with hemostatic factor - Google Patents

Medical device provided with hemostatic factor Download PDF

Info

Publication number
WO2014123381A1
WO2014123381A1 PCT/KR2014/001043 KR2014001043W WO2014123381A1 WO 2014123381 A1 WO2014123381 A1 WO 2014123381A1 KR 2014001043 W KR2014001043 W KR 2014001043W WO 2014123381 A1 WO2014123381 A1 WO 2014123381A1
Authority
WO
Grant status
Application
Patent type
Prior art keywords
body member
hemostatic
medical device
hemostatic agent
formed
Prior art date
Application number
PCT/KR2014/001043
Other languages
French (fr)
Korean (ko)
Inventor
이덕희
황선문
김태일
임옥균
장성수
Original Assignee
재단법인 아산사회복지재단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/0057Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L29/00Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/14Materials characterised by their function or physical properties, e.g. lubricating compositions
    • A61L29/16Biologically active materials, e.g. therapeutic substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/0057Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
    • A61B2017/00646Type of implements
    • A61B2017/00654Type of implements entirely comprised between the two sides of the opening
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/0057Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
    • A61B2017/00646Type of implements
    • A61B2017/00659Type of implements located only on one side of the opening
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/0057Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
    • A61B2017/00672Locating means therefor, e.g. bleed back lumen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00831Material properties
    • A61B2017/00893Material properties pharmaceutically effective
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L2400/00Materials characterised by their function or physical properties
    • A61L2400/04Materials for stopping bleeding
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/0043Catheters; Hollow probes characterised by structural features
    • A61M25/0045Catheters; Hollow probes characterised by structural features multi-layered, e.g. coated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/01Introducing, guiding, advancing, emplacing or holding catheters
    • A61M25/06Body-piercing guide needles or the like
    • A61M25/0662Guide tubes

Abstract

The present invention relates to a medical device provided with a hemostatic factor for puncturing subcutaneous tissue and an artery vessel in order to diagnose and treat various diseases such that bleeding at the puncture site is stopped when the medical device is inserted for a specific amount of time and removed, and the device comprises: a hollow body member which is inserted into an artery vessel by penetrating subcutaneous tissue; and a hemostatic agent formed on the upper surface of the body member.

Description

The medical device includes a hemostatic factor

The present invention relates to a medical device that is directed to a medical device, and more particularly, to puncture a blood vessel inserted into the subcutaneous tissue and artery was removed for a period of time for the diagnosis and treatment of different diseases.

In general, the various types of medical procedures with the human blood vessels are used and the catheter (catheter) of elongated tubular configuration, the catheter is inserted into the passage perforations between the tissue and blood vessels facilitate various medical procedures through the blood vessel from the outside It will allow you to perform.

After medical procedures using the catheter should be quickly stop the bleeding of the punctured area, the press laws this coagulation method using the hands or sand bags or pressing machines to stop the bleeding by pressing a vascular puncture site of the patient, the use of blood do.

However, the pressure method, so not only take a hemostatic time excessive, procedure time the patient must be in a motionless state during follow are many restrictions on the patient's behavior. In particular, the hemostasis during drilling portion is pressed for a long period of time is a factor which, for example, since the blood flow state is pressed, causing the medical side effects, such as deep vein thrombosis, pulmonary embolization, hematoma.

Representative hemostatic methods compensate for the problem of a pressure method has a perforated vessel closure method to stop bleeding by blocking directly the perforated region inside the vessel. The procedure of the drilling vessel closure, the method is used by a drilling vessel closure device to prevent the perforated region of the vessel directly with a biodegradable polymeric material.

Conventional hemostasis way as described above all have in common that the hemostasis proceeds to add after removal of the tube of the catheter such as that was inserted into the body, and therefore, inconvenience, and the puncture site to be provided with separate devices for hemostasis there is the issue of treatment is required, such as yet be inserted into other devices.

The present invention is equipped with a coagulation factor to be a hemostatic made accurate, hemostatic securely vessels with all the separate treatment may be omitted so as to be finely adjustable hemostasis position during withdrawing the vascular-related diagnosis and treatment after the medical device and the provision of medical equipment for that purpose.

And a hollow medical device comprising a hemostasis factor, according to one embodiment of the present invention for achieving the above problems is through the subcutaneous tissue to be inserted into the artery blood vessel body member, the hemostatic agent is formed on the upper surface of the body member It includes.

According to one embodiment of the invention, the hemostatic agent is provided any selected one of the blood coagulation promoting agent or active agent in one platelet function.

According to one embodiment of the invention, the hemostatic agent is formed in a coating manner on a predetermined region of the upper surface of the body member.

According to one embodiment of the invention, the hemostatic agent is mixed into the raw material component of the body member.

According to one embodiment of the present invention, further includes a protection member which is inserted on the outside of the body member covering said hemostatic agent before the hemostatic agent is being inserted into the subcutaneous tissue, to protect the hemostatic agent.

According to one embodiment of the invention, the body member, along the longitudinal direction on the outer surface but form a depressed discharge groove, the discharge groove is formed longer than the interval that the hemostatic agent is formed.

According to one embodiment of the invention, the hemostatic agent is, takes a concave shape inwardly along the longitudinal direction on the upper body member is filled in the receiving groove formed by plural spaced apart from each other.

According to one embodiment of the invention, the outer side of the body member, wherein the hemostatic agent is a charged receiving groove of the location and the plurality of support members in a ring shape to form a protrusion extending in a hemostatic direction so as to correspond to the upper portion than said hemostatic agent fitted.

According to one embodiment of the invention, the outer side of the body member, wherein the hemostatic agent is formed on the surface of the hemostatic member hollow shape to be inserted into the subcutaneous tissue with the body member is fitted.

According to one embodiment of the invention, the hemostatic member is provided with an elastic material, projecting to the outside along the periphery at the top is formed with a flange which over the skin.

According to the medical instrument provided with the present invention, hemostasis factors, the subject a vascular-related diagnosis and treatment after the tube in the form of bleeding in and leave the hemostatic agent in the process, the body automatically withdrawing the medical device consists of a separate treatment for hemostatic not yet punctured the hemostatic effect of the position and to be able to accurately and safely stop the bleeding because the blood vessels to leave.

1 is a perspective view of a medical device provided with a hemostatic element according to one silye of the present invention,

Figure 2 is a line A-A 'sectional view of figure 1,

Figure 3 is a perspective view of the medical device provided with a hemostatic factor in accordance with another silye of the present invention,

Figure 4 is shown a state to be inserted into the body, the medical device of Figure 3,

Figure 5 is a diagram showing the appearance of arterial blood is coming out through the discharge groove of FIG. 3,

Figure 6 is a view showing a state fixed to the body, the medical device of Figure 3,

7 is a diagram showing an appearance from the medical device exits the body of FIG. 3,

8 is a perspective view of the medical device provided with a hemostatic element according to one silye of the present invention,

9 is a B-B 'line cross-sectional view of Figure 8,

10 is a perspective view of a medical device provided with a hemostatic factor in accordance with another silye of the present invention,

Figure 11 is shown a state where the insertion into the body the medical device of Figure 10,

FIG. 12 is a diagram showing the appearance of arterial blood is coming out through the discharge groove of FIG. 10,

Figure 13 is shown the state fixed to the body, the medical device of Figure 10,

FIG. 14 is a diagram showing a state that only the remains out of the medical device body member away from the body 10 of the hemostatic agent,

Figure 15 is an exploded perspective view of the medical device provided with a hemostatic element according to one silye of the present invention,

16 is a perspective view of the medical device provided with a hemostatic element according to one silye of the present invention,

17 is a perspective view of the medical device provided with a hemostatic factor in accordance with another silye of the present invention,

Figure 18 is shown a state where the insertion into the body the medical device of Figure 17,

Figure 19 is shown a state coming out of the artery through the discharge groove of Figure 17,

Figure 20 is shown the state fixed to the body, the medical device of Figure 17,

21 shows a body member in the medical device of FIG. 17 showing a state that escapes from the body, leaving only hemostatic member.

Described in detail with reference to the accompanying drawings, the present invention. And wherein the same reference numerals for the same structure, detailed description of the repeated description, well-known functions which may unnecessarily obscure the subject matter of the present invention and configurations will be omitted. Embodiment of the present invention is provided to more completely describe the present invention to those having ordinary skill in the art. Therefore, the shape and size of the elements in the drawings may be exaggerated for more clear explanation.

1 is a perspective view of the medical device provided with a hemostatic element according to one silye of the present invention, Figure 2 is a line A-A 'sectional view of FIG.

Medical device equipped with a hemostatic factor in accordance with an embodiment of the invention the upper surface of the subcutaneous tissue 10 and through the arterial blood vessel hollow of the body member 110 to be inserted into (20) to said body member (110) and a hemostatic agent 120 to be formed on.

First, the body member 110 may be provided in a variety of medical tubes such as takes the form of a hollow tube, the catheter (catheter). Said first and second body members 110, yet the material is harmless to the human body a flexible (flexible) may be provided as a material, and for diagnosis and treatment of various diseases to puncture the subcutaneous tissue 10 and the arterial blood vessel 20 is inserted for a period of time It has been removed.

Hemostatic agent 120 to be formed on the upper surface of the body member 110, it takes the form of exposure to the outside of the body member 110. The hemostatic agent 120 of the body member 110 has been inserted into the subcutaneous tissue 10 with the body members 110 as it exits the subcutaneous tissue 10, the body member 110 as shown in Figure 7 and to stop bleeding with a puncture site naohmyeonseo away from the body, or even separate from the body member 110, such as 14 or 21 can stop bleeding arterial blood remains in the subcutaneous tissue (10) exiting through the puncture site.

According to one embodiment of the invention, the hemostatic agent 120 is provided with any selected one of the blood coagulation promoting agent or active agent in one platelet function.

The hemostat 120 is intended to prevent the body members 110 is exiting the body through the subcutaneous tissue (10) processes the subcutaneous tissue arterial blood (10) on the part punctured in exiting the rapidly solidified blood to be, as well as the active agents, such as platelet function to perform a vitamin K (K), function of the blood coagulation accelerator or a blood clot, such as calcium, which stop the bleeding of a variety of hemostatic agent known to be applied having a hemostatic function.

According to one embodiment of the invention, the hemostatic agent 120 is formed in the manner of coating or applied to the body members 110, a certain section of the top (D1).

In addition, the subcutaneous tissue with the hemostatic agent 120 includes a body member 110, while fixed by a predetermined thickness to the surface of the body member 110 in which the body member 110 is inserted into the subcutaneous tissue 10 ( has been inserted in 20), the body member 110 and at the same time out of exit, or in a variety of ways under the condition that can be left in the subcutaneous tissue 20 is separated from the body member 110 by a supporting member 130 described later body member It may be formed on (110).

According to one embodiment of the invention, the hemostatic agent 120 is mixed to the raw material component of the body member 110. In other words, the hemostatic agent 120 includes the body member 110 when manufactured in a manner such as injection, mixed with the material and then injection molding, are exposed on the surface of the body member 110 can stop the bleeding of the puncture site have.

If Figure 3, Referring to Figure 10, Figure 17, the medical device equipped with a hemostatic factor in accordance with an embodiment of the present invention, the former, the hemostatic agent 120 is inserted into the hemostatic agent 120 in the subcutaneous tissue (10) to protect fitted on the outside of the body member 110 further includes a protective member 140 to cover the hemostatic agent 120.

The protective member 140 is fitted on the outside of the body member 110, and in particular to the sandwiched interval (D1) which the hemostatic agent 120 formed protects the hemostatic agent 120. The protective member 140 may be formed of transparent material takes the shape of a hollow, to check the status of the hemostatic agent 120. The protective member 140 comprises a body member 110 when the was fitted to the outer body member 110 and the hemostatic agent 120 of the body member 110, the insertion to the body member 110 until the body is inserted into the body in can be separated.

According to one embodiment of the invention, the body member 110, in the longitudinal direction on the outer surface but form a depressed discharge groove 112, the interval (D2) of the discharge groove 112 is formed is a hemostatic agent 120 is formed longer than the defined period (D1), to determine the arterial blood comes out located along the discharge groove 112 outside of the body member 110 is to judge whether the inserted arteries 20 be so.

5, 12 and the discharge groove 112, as shown in Figure 19 is formed longitudinally on the outer surface of the body member 110. The discharge groove 112 is formed to be longer than the interval (D1) which the hemostatic agent 120 is formed, the reason is to hemostatic agent 120 from being inserted into the artery 20. Therefore, in the insertion of the body member 110, the subcutaneous tissue 10 and the arterial blood vessel 20, when the lower end of the discharge groove 112 is inserted into the artery 20, and arterial blood is the discharge groove ( 112) with the inlet and the arterial blood to exit through the upper end of the discharge groove 112 in the body. In this case, the doctor or the nurse who conducted the diagnosis and treatment are reported the arterial blood coming out into the outer body member 110 can confirm that properly inserted into the artery 20, at the same time there no arterial blood out into the discharge recess 112 prevent pulled over the body member 110 to the outside. At this time, the discharge groove 112, even if it extends out of the artery 20, the lower end of the body member 110 has to maintain the state inserted into the artery 20. Accordingly, the discharge grooves 112 may be formed apart from each other by a distance (D3) from the lower end of the body of a predetermined member (110).

Hereinafter, with reference to Fig. 4 to 7, it is described the use of having the above-described medical device element hemostasis example as follows.

First, the insertion of the body member 110 into the body to remove the entire protective member 140. The Then, to puncture the subcutaneous tissue 10 to insert the body member 110 into the body. In the process, a hemostatic agent 120 is formed on the surface of the body member 110 is inserted into the subcutaneous tissue 10, with the body member 110. The inserted body member 110 through the subcutaneous tissue (10), reaches the arterial blood vessel 20 and, when inserted further by a predetermined length (D3), it is formed concave in the longitudinal direction on the outer surface of the body member (110) discharging groove is the arterial blood out through 112 out to the outside, from the outside can see that the body member 110 arrives at the arterial blood vessel 20. And fixing its position, remove the body member 110 by pulling gently discharge groove 112 to the outside edges of the blood vessel in the artery 20 to prevent the arterial blood exiting the discharge groove 112. The This can be confirmed based on whether this arterial blood comes out out of the discharge groove (112). When the position of the body member 110 is fixed, such as the doctor or the nurse to diagnose or treat the patient. Then, the pulled out when the patient diagnosis and treatment is complete, the body member 110 in the subcutaneous tissue 10 and the arterial blood vessel 20. In this case, the hemostatic agent 120 naohmyeonseo away from the body with the body member 110, and thereby the bleeding puncture site.

8 is a perspective view of the medical device provided with a hemostatic element according to one silye of the present invention, Figure 9 is a B-B 'line cross-sectional view of Fig. According to one embodiment of the invention, the hemostatic agent 120 includes the body member 110 takes the form of concave inward along the longitudinal direction at a constant interval (D1) of the upper, receiving the spaced apart from each other are formed plural groove (111 ) it is charged to. To the receiving groove 111 is formed concave in the longitudinal direction of the body member 110 to the outer surface of the body member 110 may be formed in plurality in parallel to each other and spaced with a predetermined distance. If the receiving groove 111 is formed as described above and improves the fixing force because take the form of a hemostatic agent 120 accommodated in the receiving groove 111, in particular the body member 110 is inserted into the subcutaneous tissue 10 while it may not release and separate from the body member 110.

Note that in the receiving groove 111 is the hemostatic process, the receiving groove 111 at 120 may be formed only in the interval (D1) is formed, taking out at a later body member subcutaneous tissue above the 110, 10 the separation of the hemostatic agent received 120 easy to extend to the lower end of the body member 110 may be formed. In addition, the lower portion of the inclined surface of the receiving groove 111, the body member even if it is not formed up to the lower end of the unit 110, the receiving groove hemostatic agent 120, the receiving groove 111 so as to discharge the easily formed in the (111) It can be formed.

According to one embodiment of the invention, the outer side of the body member 110, the hemostatic agent 120, the position and the hemostatic agent 120, a plurality of protrusions (131 extend in a direction so as to correspond of the filled receiving groove (111) ) ring-shaped supporting member 130 is formed to the fitted to the upper part than said hemostatic agent 120.

Support members 130 may take the form of a ring, is fitted to the upper than the hemostatic agent 120 of the body member 110. The support member 130 when pulled out from the body member 110, a hemostatic agent (120) intended to separate from the body member 110, the subcutaneous tissue 10 of the body member 110 is formed on the support member ( 130) from the supported state in contact with the skin (30), remove only the body member 110 remains in the hemostatic agent 120 includes a subcutaneous tissue 10 does not get out from the body by the action of the body member 110 hemostatic this will be done so.

The projecting portion 131 while being supported in contact with the skin 30, while that to aid the separation of the hemostatic agent 120 filled in the receiving groove 111, wherein the body member 110 to break out of the subcutaneous tissue (10) the end is inserted in the receiving groove 111 of the body member 110, presses the hemostatic agent 120 filled in the receiving groove 111 acts so that the hemostatic agent 120 can be left in the subcutaneous tissue (10). In this case, the receiving groove 111 is formed to extend to the upper portion to allow the receiving projections 131 formed in the support member 130, instead of being formed on only the interval (D1) which the hemostatic agent 120 formed projections ( 131) a receiving groove (in contained in 111) urging the hemostatic state 120, separation of the hemostatic agent 120 may be so reliably achieved more.

Referring now to Figs. 11 to 14, is described the use of having the above-described medical device element hemostasis example as follows.

First, the insertion of the body member 110 into the body to remove the entire protective member 140. The Then, to puncture the subcutaneous tissue 10 to insert the body member 110 into the body. In the process, a hemostatic agent 120 is formed on the surface of the body member 110 is inserted into the subcutaneous tissue 10, with the body member 110. The inserted body member 110 through the subcutaneous tissue (10), reaches the arterial blood vessel 20 and, when inserted further by a predetermined length (D3), it is formed concave in the longitudinal direction on the outer surface of the body member (110) discharging groove is the arterial blood out through 112 out to the outside, from the outside can see that the body member 110 arrives at the arterial blood vessel 20. And fixing its position, remove the body member 110 by pulling gently discharge groove 112 to the outside edges of the blood vessel in the artery 20 to prevent the arterial blood exiting the discharge groove 112. The This can be confirmed based on whether this arterial blood comes out out of the discharge groove (112). When the position of the body member 110 is fixed, such as the doctor or the nurse to diagnose or treat the patient. Then, the pulled out when the patient diagnosis and treatment is complete, the body member 110 in the subcutaneous tissue 10 and the arterial blood vessel 20. At this time, in vitro by the action of the hemostatic agent 120 includes a support member 130 formed of the support member 130, an inner surface to remove the body member 110 in the supporting state by contacting the skin on the outer surface of the body member 110 does not get out remain in the subcutaneous tissue (10) is a hemostatic puncture site into.

15 is an exploded perspective view of the medical device provided with a hemostatic element according to one silye of the present invention, Figure 16 is a perspective view of the medical device provided with a hemostatic element according to one silye of the present invention. According to one embodiment of the invention, the body, the outer side of the member 110, the hemostatic agent 120 is formed on a surface of the body member of hollow form hemostasis member that is inserted into the subcutaneous tissue 10, with 110 the 150 is fitted. In other words, the hemostatic agent 120 may be formed in a manner such as coating the inside, the outside surface of, or contained in the raw material components of the hemostatic member 150, a hemostatic member (150). The hemostasis member 150 as described above was inserted into the subcutaneous tissue 10, with the body member 110, comes out of the body member 110 is away from the body, separate from the body member 110 remains in the body then the bleeding puncture site.

According to one embodiment of the invention, the hemostatic member 150, it is provided with an elastic material, projecting to the outside along the periphery at the top is formed with a flange 151 that is across the skin.

The hemostasis member 150 may be provided in a variety of resilient materials, including rubber, silicone or the like. Top around the hemostatic member (150) being fitted in the body member 110 retains its shape by the flange 151 of the circle, but the bottom is either state ohmeura by an elastic, at the bottom of a narrow aperture (152 etc.) or the sheath is formed. Then, the hemostatic member (150) when fitted to the body member 110, the hemostasis member 150 is stretched by an elastic, through holes 152 were confined to automatically extend as the outer diameter of the body member (110) .

With reference to FIGS. 18 to 21, it is described the use of having the above-described medical device element hemostasis example as follows.

First, the insertion of the body member 110 into the body to remove the entire protective member 140. The Then, to puncture the subcutaneous tissue 10 to insert the body member 110 into the body. In the process, hemostatic member 150 formed on the surface of the body member 110 is inserted into the subcutaneous tissue 10, with the body member 110. The inserted body member 110 through the subcutaneous tissue (10), reaches the arterial blood vessel 20 and, when inserted further by a predetermined length (D3), it is formed concave in the longitudinal direction on the outer surface of the body member (110) discharging groove is the arterial blood out through 112 out to the outside, from the outside can see that the body member 110 arrives at the arterial blood vessel 20. And fixing its position, remove the body member 110 by pulling gently discharge groove 112 to the outside edges of the blood vessel in the artery 20 to prevent the arterial blood exiting the discharge groove 112. The This can be confirmed based on whether this arterial blood comes out out of the discharge groove (112). When the position of the body member 110 is fixed, such as the doctor or the nurse to diagnose or treat the patient. Then, When the body member 110 is away from the body, hemostatic member 150 comprises a body member in a state of supporting the body member are separated from 110 to which it remains in the body, the flange 151 to the skin ( in such a way to steal 110) it can be separated from the hemostasis member 150 and the body member 110. The hemostasis member 150 separated from the body member 110 is restored to the original shape by the elasticity, as the like of the through holes 152, which expand or to narrow expansion sheath shielding to block the arterial blood exiting through the puncture site and, it is possible to stop the bleeding puncture site under the action of the surface of a hemostatic agent 120.

A medical device provided with a hemostatic factor in accordance with the present invention as described above, the blood vessel so as to consist of a hemostasis can finely adjust the yet hemostasis location for a separate treatment may be omitted in the process of withdrawing the vascular-related diagnosis and treatment after the medical device there are advantages that can accurately and safely stop the bleeding.

The above description, those skilled in the art be a variety of modifications, alterations, and substitutions within the scope without departing from the essential characteristics of the present invention as only those described technical features of the present invention by way of example will be. Accordingly, the drawings the embodiments and the accompanying disclosed invention are not intended to be is for illustrative and not intended to limit the technical idea of ​​the present invention, only this embodiment and the technical scope of the present invention by the accompanying drawings, . The scope of protection of the invention is to be interpreted by the following claims, all spirits within a scope equivalent will be construed as included in the scope of the present invention.

Claims (10)

  1. In the medical instrument of the tubular to be removed has been inserted for a period of time in the subcutaneous tissue to expose the artery puncture,
    A hollow body member is inserted into the artery through the subcutaneous tissue;
    A medical device provided with a hemostatic element comprises a; hemostatic agent formed on the upper surface of the body member.
  2. According to claim 1,
    The hemostatic agent is a medical device comprising a hemostasis factor, characterized in that the provided any selected one of the blood coagulation promoting agent and the active agent to one platelet function.
  3. According to claim 1,
    The hemostatic agent is a medical device comprising a hemostasis factor, characterized in that formed in a coating manner on a regular interval on the upper surface of the body member.
  4. According to claim 1,
    The hemostatic agent is a medical device provided with a hemostatic element characterized in that the mixture of the raw material components of the body member.
  5. According to claim 1,
    Said hemostatic agent is a coagulation factor, characterized in that it further comprises a protective member fitted on the outer side of the body member covering said hemostatic agent adapted to protect the former, the hemostat is inserted into the subcutaneous tissue medical device.
  6. According to claim 1,
    It said body member, along the longitudinal direction on the outer surface but form a depressed discharge groove, the discharge groove is a medical device comprising a hemostasis factor, characterized in that formed longer than the interval that the hemostatic agent is formed.
  7. According to claim 1,
    The hemostatic agent is a medical device comprising, a hemostasis factor, characterized in that spaced apart from each other by taking the concave shape inwardly along the longitudinal direction on the upper body member formed with a plurality of charge receiving groove.
  8. The method of claim 7,
    The outer side of the body member, a hemostasis factor, characterized in that a plurality of support members in a ring shape to form a protrusion extending in a hemostatic direction is fitted to the upper than said hemostatic agent to the hemostatic agent, in correspondence with the position of the filled receiving groove equipped medical equipment.
  9. According to claim 1,
    The outer side of the body member, wherein the hemostatic agent is formed on the surface of the hemostatic elements provided, characterized in that interposed between the hemostatic member of the hollow shape to be inserted into the subcutaneous tissue with the medical device body members.
  10. 10. The method of claim 9,
    The hemostasis member is provided with an elastic material, projecting to the outside along the periphery at the top of the medical device comprising a hemostasis factor, it characterized in that a flange which is formed across the skin.
PCT/KR2014/001043 2013-02-08 2014-02-07 Medical device provided with hemostatic factor WO2014123381A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
KR10-2013-0014601 2013-02-08
KR20130014601A KR20140101502A (en) 2013-02-08 2013-02-08 Vascular sheath having hemostatic component

Publications (1)

Publication Number Publication Date
WO2014123381A1 true true WO2014123381A1 (en) 2014-08-14

Family

ID=51299925

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2014/001043 WO2014123381A1 (en) 2013-02-08 2014-02-07 Medical device provided with hemostatic factor

Country Status (2)

Country Link
KR (1) KR20140101502A (en)
WO (1) WO2014123381A1 (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006055337A (en) * 2004-08-19 2006-03-02 Bridgestone Corp Catheter sheath
KR20060050358A (en) * 2004-08-11 2006-05-19 코디스 코포레이션 Kit for applying drug coating to a medical device in surgeon room
US20100168767A1 (en) * 2008-06-30 2010-07-01 Cardiva Medical, Inc. Apparatus and methods for delivering hemostatic materials for blood vessel closure
KR20100102750A (en) * 2005-04-25 2010-09-24 메사추세츠 인스티튜트 오브 테크놀로지 Compositions and methods for promoting hemostasis and other physiological activities
CN102697531A (en) * 2012-05-28 2012-10-03 王学凡 Titanium nail with hemostatic medicine coating

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20060050358A (en) * 2004-08-11 2006-05-19 코디스 코포레이션 Kit for applying drug coating to a medical device in surgeon room
JP2006055337A (en) * 2004-08-19 2006-03-02 Bridgestone Corp Catheter sheath
KR20100102750A (en) * 2005-04-25 2010-09-24 메사추세츠 인스티튜트 오브 테크놀로지 Compositions and methods for promoting hemostasis and other physiological activities
US20100168767A1 (en) * 2008-06-30 2010-07-01 Cardiva Medical, Inc. Apparatus and methods for delivering hemostatic materials for blood vessel closure
CN102697531A (en) * 2012-05-28 2012-10-03 王学凡 Titanium nail with hemostatic medicine coating

Also Published As

Publication number Publication date Type
KR20140101502A (en) 2014-08-20 application

Similar Documents

Publication Publication Date Title
US3585996A (en) Arterial catheter placement unit and method of use
US3490448A (en) Adhesive pressure pad
US5817052A (en) Apparatus for intraosseous infusion or aspiration
US4693704A (en) Cervical canal catheter
US5713855A (en) Pressure applying fluid transfer medical method
US4338941A (en) Apparatus for arresting posterior nosebleeds
US3954109A (en) Bandage to prevent local hematoma
US20080132821A1 (en) Window dressing
US5108375A (en) Closed system canulating device
US5269803A (en) Hemostasis pressure pad band
US20050049626A1 (en) Fistula blocker
US4998921A (en) Intermittent I.V. therapy needle sheath
US6007562A (en) Puncture closure
US5649959A (en) Assembly for sealing a puncture in a vessel
US5527297A (en) Syringe splash guard
US5520654A (en) Catheter device
US5643315A (en) Device for wound therapy and prevention of bleeding
US20050288620A1 (en) Nose pack method and apparatus
US5840055A (en) Disposable device for transfer of an active liquid into an intracorporeal cavity
US7129389B1 (en) Puncture site patch
US20050125025A1 (en) Styptic device
US6960181B2 (en) Irrigation dressing with a tubular dam
US20070043326A1 (en) Device for fixing a catheter to the body of a patient
US5496264A (en) Hemostatic transdermal injection appliance
US8118832B1 (en) Method and apparatus for sealing access

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 14748482

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase in:

Ref country code: DE

122 Ep: pct app. not ent. europ. phase

Ref document number: 14748482

Country of ref document: EP

Kind code of ref document: A1